IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
2,350,848
2,213,242
1,969,058
1,775,423
1,601,892
Cost of Revenue
1,016,087
971,700
871,676
799,987
711,622
Gross Profit
1,334,761
1,241,542
1,097,382
975,436
890,270
Operating Expenses
Research Development
128,171
117,863
109,182
101,122
99,681
Selling General and Administrative
654,028
632,344
575,172
524,075
482,465
Total Operating Expenses
782,199
750,207
684,354
625,197
582,146
Operating Income or Loss
552,562
491,335
413,028
350,239
308,124
Interest Expense
32,222
33,593
31,971
28,393
26,771
Total Other Income/Expenses Net
-
-
-
0
-8,212
Income Before Tax
520,757
457,742
381,057
321,846
273,141
Income Tax Expense
97,832
80,695
117,788
99,792
81,006
Income from Continuing Operations
422,925
377,047
263,269
222,054
192,135
Net Income
422,862
377,031
263,144
222,045
192,078
Net Income available to common shareholders
407,276
377,031
263,144
222,045
192,078
Reported EPS
Basic
-
4.34
3.00
2.47
2.07
Diluted
-
4.26
2.94
2.44
2.05
Weighted average shares outstanding
Basic
-
86,864
87,769
89,732
92,601
Diluted
-
88,470
89,567
90,884
93,649
EBITDA
-
491,335
413,028
350,239
299,912